Catalyst Pharmaceuticals (CPRX) Net Income Growth (1y) (2011 - 2026)
Catalyst Pharmaceuticals (CPRX) Net Income Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - | -0.46% |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - | - |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - | - |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn | 63.48% |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn | 1,228.66% |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 12.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.33% |
| Dec 31, 2025 | 11.46% |
| Sep 30, 2025 | 20.28% |
| Jun 30, 2025 | 27.73% |
| Mar 31, 2025 | 143.77% |
| Dec 31, 2024 | 228.28% |
| Sep 30, 2024 | 242.65% |
| Jun 30, 2024 | 8.03% |
| Mar 31, 2024 | -21.28% |
| Dec 31, 2023 | -33.10% |
| Sep 30, 2023 | -235.24% |
| Jun 30, 2023 | 74.67% |
| Mar 31, 2023 | 123.31% |
| Dec 31, 2022 | 173.62% |
| Sep 30, 2022 | 120.23% |
| Jun 30, 2022 | 77.48% |
| Mar 31, 2022 | 72.79% |
| Dec 31, 2021 | -18.61% |
| Sep 30, 2021 | -76.17% |
| Jun 30, 2021 | 24.55% |